Lorente, David
Mateo, Joaquin
Zafeiriou, Zafeiris
Smith, Alan D.
Sandhu, Shahneen
Ferraldeschi, Roberta
de Bono, Johann S.
Article History
First Online: 7 January 2015
Competing interests
: J.S.d.B. has received consulting fees from Ortho Biotech Oncology Research and Development (a unit of Cougar Biotechnology), consulting fees and travel support from Amgen, Astellas, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Dendreon, Enzon, Exelixis, Genentech, GlaxoSmithKline, Medivation, Merck, Novartis, Pfizer, Roche, Sanofi–Aventis, Supergen, and Takeda, and grant support from AstraZeneca and Genentech. D.L., J.M., Z.Z., A.D.S., S.S. and R.F. declare no competing interests.